Todays Biggest Pre-Market Stock Movers 10 Top Gainers and Losers onWednesday

Slightly above 67% of VBI Vaccines' investor base is looking to short. The analysis of current outlook of investing in VBI Vaccines suggests that many traders are alarmed regarding VBI Vaccines' prospects. VBI Vaccines' investing sentiment can be driven by a variety of factors including economic data, VBI Vaccines' earnings reports, geopolitical events, and overall market trends.
  
Pre-market stock movers are a hot topic on Wednesday and we have all of the latest news traders need to know about them this morning

Read at investorplace.com
sbwire news
  

VBI Vaccines Fundamental Analysis

We analyze VBI Vaccines' financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of VBI Vaccines using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of VBI Vaccines based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.

EBITDA

EBITDA Comparative Analysis

VBI Vaccines is currently under evaluation in ebitda category among its peers. EBITDA stands for earnings before interest, taxes, depreciation, and amortization. It is a measure of a company operating cash flow based on data from the company income statement and is a very good way to compare companies within industries or across different sectors. However, unlike Operating Cash Flow, EBITDA does not include the effects of changes in working capital.

VBI Vaccines Potential Pair-trading

One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with VBI Vaccines stock to make a market-neutral strategy. Peer analysis of VBI Vaccines could also be used in its relative valuation, which is a method of valuing VBI Vaccines by comparing valuation metrics with similar companies.

Peers

VBI Vaccines Related Equities

ANVSAnnovis Bio   12.33   
0%
100.0%
ALLOAllogene Therapeutics   7.18   
0%
58.0%
JAGXJaguar Animal   5.10   
0%
41.0%
BBIOBridgeBio Pharma   4.83   
0%
39.0%
IBIOIbio   2.54   
0%
20.0%
GOVXGeoVax Labs   2.26   
0%
18.0%
VXRTVaxart   1.67   
0%
13.0%
ARDXArdelyx   1.31   
0%
10.0%
AKROAkero Therapeutics   0.67   
0%
5.0%
AUPHAurinia Pharmaceuticals   0.34   
0%
2.0%
TNXPTonix Pharmaceuticals   2.50   
20.0%
0%
OCGNOcugen   2.70   
21.0%
0%
ANIXAnixa Biosciences   4.09   
33.0%
0%
Check out World Market Map to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in gross domestic product.
You can also try the Volatility Analysis module to get historical volatility and risk analysis based on latest market data.

Other Consideration for investing in VBI Stock

If you are still planning to invest in VBI Vaccines check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the VBI Vaccines' history and understand the potential risks before investing.
Share Portfolio
Track or share privately all of your investments from the convenience of any device
Theme Ratings
Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance
Portfolio Diagnostics
Use generated alerts and portfolio events aggregator to diagnose current holdings
Fundamental Analysis
View fundamental data based on most recent published financial statements
Equity Forecasting
Use basic forecasting models to generate price predictions and determine price momentum
Commodity Channel
Use Commodity Channel Index to analyze current equity momentum
Stock Screener
Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook.
Analyst Advice
Analyst recommendations and target price estimates broken down by several categories
Cryptocurrency Center
Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency